Direct-to-consumer prescription drug advertising

被引：34

作者：

Bradley, LR ^{[1
]}

Zito, JM ^{[1
]}

机构：

[1] UNIV MARYLAND,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21201

来源：

MEDICAL CARE | 1997年 / 35卷 / 01期

关键词：

D O I：

10.1097/00005650-199701000-00008

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

[No abstract available]

引用

页码：86 / 92

页数：7

共 15 条

[1]

ADAMS DG, 1992, J PHARM MARKET MGT, V7, P53

[2]

COHEN EP, 1988, NEW ENGL J MED, V18, P373

[3]

*COMM DRUGS AM AC, 1991, PEDIATRICS, V88, P1745

[4]

*HLTH ACT INT, 1992, PROM HLTH PUSH DRUGS

[5]

INGRAM RA, 1992, J PHARM MARKETING MA, V7, P67

[6]

KEITH A, 1992, J PHARM MARKETING MA, V7, P121

[7] THE FEDERAL-REGULATION OF PRESCRIPTION DRUG ADVERTISING AND PROMOTION [J].

KESSLER, DA ;

PINES, WL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (18) :2409-2415

[8] THERAPEUTIC-CLASS WARS - DRUG PROMOTION IN A COMPETITIVE MARKETPLACE [J].

KESSLER, DA ;

ROSE, JL ;

TEMPLE, RJ ;

SCHAPIRO, R ;

GRIFFIN, JP .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (20) :1350-1353

[9] ASHP POSITION ON DIRECT-TO-CONSUMER ADVERTISING OF PRESCRIPTION DRUG PRODUCTS [J].

PIERPAOLI, PG .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (07) :1763-1764

[10]

PINES WL, 1992, J PHAR MARK MANAGE, V7, P87

← 1 2 →